Active

Mission BioCapital

General contacts

Investor type

PE / VC

Founded

2009

AUM

$500 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Pre-seed Series A Series B

Region of investment

North America Europe

Investor profile last updated: 03 August, 2026

Profile

Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, founded in 2009. The firm is composed of scientists, investors, founders, and serial entrepreneurs with a focus on empowering life science entrepreneurs. They provide early-stage capital and support through a shared labs model, offering lab space and mentorship to accelerate the development of scientific solutions.

The firm primarily invests in the life sciences and biotechnology sectors, focusing on early-stage companies. They typically invest up to $500K per company and offer additional services through their Platinum Program. Mission BioCapital invests in the United States and Europe, with a portfolio that includes companies like Alector, Pandion, and Mitokinin. They are currently investing out of their fifth fund, Mission BioCapital V LP, with an AUM of $275 million.

Notable investments by Mission BioCapital include Alector - a biotechnology company, Pandion - a drug discovery firm, Mitokinin - a biotech company, Nocion Therapeutics - focused on drug discovery, and QurAlis - a biotech firm. These investments highlight their commitment to advancing life sciences and biotechnology innovations.

Industry

Biotechnology Chemicals Fashion/Beauty Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech Food and Beverage Foodtech

Mission BioCapital Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Mission BioCapital V LP	Fund of funds	Fashion/Beauty Food and Beverage Foodtech Healthcare Services HealthTech	Seed Series A Series B	North America	$5-10 m	$275 M	November 2021
Mission BioCapital VI Fund	Fund of funds	Fashion/Beauty Food and Beverage Foodtech Healthcare Services HealthTech	Seed Series A Series B	North America	$5-10 m	$134 M	September 2025

Contacts

Name

Title

Social Networks

Steve Tregay Managing General Partner

Managing General Partner

s•••@•••

Ulrik B. Nielsen General Partner

General Partner

u•••@•••

Upgrade to see contacts

WXxVHiJcp2U3eqP4 WXxVHiJcp2U3eqP4

WXxVHiJcp2U3eqP4

[email protected]

WXxVHiJcp2U3eqP4 WXxVHiJcp2U3eqP4

WXxVHiJcp2U3eqP4

[email protected]

WXxVHiJcp2U3eqP4 WXxVHiJcp2U3eqP4

WXxVHiJcp2U3eqP4

[email protected]

Investment-team contacts for Mission BioCapital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Mission BioCapital

Is Mission BioCapital a venture capital or private equity firm?

Mission BioCapital is a venture capital and private equity firm. It backs companies at Seed, Pre-seed, Series A and Series B, writing tickets of $0-1 m.

Where is Mission BioCapital located?

Mission BioCapital is located in Cambridge, Massachusetts, United States.

When was Mission BioCapital founded?

Mission BioCapital was founded in 2009.

What sectors and industries does Mission BioCapital invest in?

Mission BioCapital invests in companies and startups in Biotechnology, Chemicals, Fashion/Beauty, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech, Food and Beverage, Foodtech.

What is Mission BioCapital geographical focus of investments?

Mission BioCapital invests in companies and startups in North America, Europe.

At what stages of companies and startups does Mission BioCapital typically invest in?

Mission BioCapital invests in companies and startups at Seed, Pre-seed, Series A, Series B.

What is the usual amount of Mission BioCapital investment?

Mission BioCapital usually invests $0-1 m on average.

What is the amount of assets of under management (AUM) for Mission BioCapital?

Mission BioCapital has around $500m assets under management.

When was Mission BioCapital last fund created?

Mission BioCapital last fund was created/launched in 2025-09-19

What are the contacts of Mission BioCapital?

Mission BioCapital can be reached through its website missionbiocapital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Mission BioCapital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Mission BioCapital data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Mission BioCapital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Mission BioCapital profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 03 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.